Suchergebnisse - "Spinner, Christoph D"

PubPharm (9)

1

No Remdesivir Resistance Observed in the Phase 3 Severe and Moderate COVID-19 SIMPLE Trials

enthalten in: Viruses | 2024

von Hedskog, C. | Spinner, C. | Protzer, U. | +24

2

Use and effectiveness of remdesivir for the treatment of patients with covid-19 using data from the Lean European Open Survey on SARS-CoV-2 infected patients (LEOSS) : a multicentre cohort study

enthalten in: Infection | 2023

von Pilgram, L. | Appel, K. | Ruethrich, M. | +15

3

Low Spontaneous Clearance Rates of Recently Acquired Hepatitis C Virus in Human Immunodeficiency Virus-Positive Men Who Have Sex With Men (PROBE-C Study)

enthalten in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America | 2023

von Monin, M. | Ingiliz, P. | Lutz, T. | +13

4

Phase IIa Proof-of-Concept Evaluation of the Antiviral Efficacy, Safety, Tolerability, and Pharmacokinetics of the Next-Generation Maturation Inhibitor GSK3640254

enthalten in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America | 2022

von Spinner, C. | Felizarta, F. | Rizzardini, G. | +16

5

Efficacy and safety of baricitinib for the treatment of hospitalised adults with COVID-19 (COV-BARRIER) : a randomised, double-blind, parallel-group, placebo-controlled phase 3 trial

enthalten in: The Lancet. Respiratory medicine | 2021

von Marconi, V. | Ramanan, A. | de Bono, S. | +105

CommentIn: Lancet Respir Med. 2021 Dec;9(12):1349-1351. - PMID 34480862

6

Remdesivir for Early COVID-19 Treatment of High-Risk Individuals Prior to or at Early Disease Onset-Lessons Learned

enthalten in: Viruses | 2021

von Dölken, L. | Stich, A. | Spinner, C.

7

Remdesivir for 5 or 10 Days in Patients with Severe Covid-19

enthalten in: The New England journal of medicine | 2020

von Goldman, J. | Lye, D. | Hui, D. | +71

CommentIn: N Engl J Med. 2020 Nov 5;383(19):1886-1887. - PMID 32459913

8

Effect of Remdesivir vs Standard Care on Clinical Status at 11 Days in Patients With Moderate COVID-19 : A Randomized Clinical Trial

enthalten in: JAMA | 2020

von Spinner, C. | Gottlieb, R. | Criner, G. | +28

CommentIn: JAMA. 2020 Sep 15;324(11):1041-1042. - PMID 32821934

9

Ledipasvir plus sofosbuvir fixed-dose combination for 6 weeks in patients with acute hepatitis C virus genotype 1 monoinfection (HepNet Acute HCV IV) : an open-label, single-arm, phase 2 study

enthalten in: The Lancet. Infectious diseases | 2017

von Deterding, K. | Spinner, C. | Schott, E. | +20

CommentIn: Lancet Infect Dis. 2017 Feb;17(2):125-127. - PMID 28029528

1
[1]